Related Experiment Videos
[Gastrin and colorectal cancer]
C Casella1, F Palmieri, M G Fontana
1Università degli Studi di Brescia, Cattedra di Chirurgia generale, Cattedra.
Annali Italiani Di Chirurgia
|July 24, 2001
Summary
Serum gastrin levels showed no significant variation before and after colorectal cancer surgery. These levels did not appear to predict patient outcomes or prognosis in this study.
Area of Science:
- Gastroenterology
- Oncology
- Surgical Oncology
Context:
- Colorectal cancer (CRC) is a significant global health concern.
- Accurate prognostic markers are crucial for tailoring CRC treatment strategies.
- Serum gastrin's role as a prognostic indicator in CRC remains unclear.
Purpose:
- To evaluate preoperative and postoperative serum gastrin level variations in colorectal cancer patients.
- To determine the prognostic value of serum gastrin levels in predicting 5-year survival for colorectal cancer.
Summary:
- This study analyzed serum gastrin levels in 66 colorectal cancer patients undergoing curative surgery.
- No significant association was found between gastrin levels and tumor characteristics (site, stage, grade).
- Neither preoperative nor postoperative gastrin levels demonstrated a significant impact on 5-year survival rates.
Impact:
- Serum gastrin levels do not appear to possess prognostic value in colorectal cancer.
- Findings suggest gastrin is not a reliable biomarker for predicting CRC outcomes.
- Further research with larger cohorts may be warranted to definitively establish gastrin's role.